Company Filing History:
3 out of 321 
1 out of 1,247 
Years Active: 2012-2013
Title: Inventor Eun-Jung Song: A Pioneer in Antibody Development
Introduction
Eun-Jung Song is an esteemed inventor based in Daejeon, South Korea, known for his significant contributions to the field of biotechnology. With a remarkable count of three patents, his work primarily focuses on innovative human antibodies that hold promise in cancer diagnosis and treatment.
Latest Patents
Song's most recent patents include groundbreaking inventions such as the TMPRSS4-specific human antibody and the VEGF-specific human antibody. The TMPRSS4-specific human antibody is designed to target the transmembrane protease, serine (TMPRSS4), and has potential applications in diagnosing various cancers, classifying diseases, providing visualization, treatment, and prognostic evaluation. On the other hand, the VEGF-specific human antibody is aimed at combating diseases associated with vascular endothelial growth factor (VEGF) overexpression, allowing for similar applications in diagnosis, classification, treatment, and prognostic evaluation.
Career Highlights
Eun-Jung Song has had an impactful career with a notable track record of research and development. He has contributed to the advancement of antibody technologies through his innovative ideas and scientific rigor. His patents reflect a deep understanding of the intricate mechanisms behind cancer and their targeted treatments.
Collaborations
Throughout his career, Song has collaborated with leading organizations in the field. He has worked with the Korea Research Institute of Bioscience and Biotechnology and the Sungkyunkwan University Foundation for Corporate Collaboration. His teamwork with notable coworkers, including Young Woo Park and So-Young Choi, has led to fruitful advancements in biotechnology and innovative research.
Conclusion
Eun-Jung Song continues to be a vital force in the realm of biotechnology through his innovative inventions and collaborations. His work on TMPRSS4-specific and VEGF-specific human antibodies not only enhances our understanding of cancer treatment but also showcases the promising potential of targeted therapies. Through his contributions, Song exemplifies the spirit of innovation and the impact of dedicated research in transforming healthcare.